Literature DB >> 25131570

Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories.

Jessica Howell1, Caroline Van Gemert, Maud Lemoine, Mark Thursz, Margaret Hellard.   

Abstract

There are over 500-750 000 deaths per year because of hepatitis B virus (HBV)-related cirrhosis and liver cancer worldwide and the World Health Organization Western Pacific Region has some of the highest endemic levels of HBV in the world, particularly within China, South East Asia and Pacific Island Countries and Territories (PICT). The PICT have unique ethnic diversity and a very high prevalence of smoking and metabolic syndrome, both important risk factors for liver fibrosis and liver cancer. However, in contrast to many Asian countries, there is little published data on HBV prevalence and related liver disease burden in PICT. In this review, the available published literature and World Health Organization data for HBV prevalence and related liver disease and liver cancer burden in PICT is outlined, and unmet needs for improving HBV prevention and control in the region are highlighted.
© 2014 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Melanesian; Micronesian; Pacific Islands; Polynesian; cirrhosis; hepatocellular carcinoma; liver cancer; liver disease; viral hepatitis

Mesh:

Year:  2014        PMID: 25131570     DOI: 10.1111/jgh.12684

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  7 in total

Review 1.  Cancer control in the Pacific: big challenges facing small island states.

Authors:  Diana Sarfati; Rachel Dyer; Filipina Amosa-Lei Sam; Michael Barton; Freddie Bray; Eka Buadromo; Alec Ekeroma; Sunia Foliaki; James Fong; Josephine Herman; Linda Huggins; Kiki Maoate; Ineke Meredith; Glen Mola; Neal Palafox; Viliami Puloka; Hai-Rim Shin; Jane Skeen; Wendy Snowdon; Malama Tafuna'i; Andrea Teng; David Watters; Paula Vivili
Journal:  Lancet Oncol       Date:  2019-08-05       Impact factor: 41.316

2.  Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.

Authors:  Shigui Yang; Chengbo Yu; Ping Chen; Min Deng; Qing Cao; Yiping Li; Jingjing Ren; Kaijin Xu; Jun Yao; Tiansheng Xie; Chencheng Wang; Yuanxia Cui; Cheng Ding; Guo Tian; Bing Wang; Xiaoyan Zhang; Bing Ruan; Lanjuan Li
Journal:  Sci Rep       Date:  2015-12-14       Impact factor: 4.379

3.  Predictors of response to pegylated interferon in chronic hepatitis B: a real-world hospital-based analysis.

Authors:  Yin-Chen Wang; Sien-Sing Yang; Chien-Wei Su; Yuan-Jen Wang; Kuei-Chuan Lee; Teh-Ia Huo; Han-Chieh Lin; Yi-Hsiang Huang
Journal:  Sci Rep       Date:  2016-07-12       Impact factor: 4.379

4.  A system dynamics modelling simulation based on a cohort of hepatitis B epidemic research in east China community.

Authors:  Zhixin Yu; Min Deng; Chunting Peng; Xue Song; Yi Chen; Xue Zhang; Qiuxia Liu; Yuchuan Li; Haiyin Jiang; Xiaolan Xu; Liya Pan; Jing Yuan; Bing Ruan
Journal:  Epidemiol Infect       Date:  2019-02-28       Impact factor: 2.451

5.  Factors associated with risk behaviours towards hepatitis B among migrant workers: a cross-sectional study based on theory of planned behaviour.

Authors:  Hui Xiang; Mingjing Li; Meng Xiao; Min Liu; Xiaoshan Su; Dashu Wang; Ke Li; Rui Chen; Lin Gan; Kun Chu; Yu Tian; Xiaojun Tang; Xun Lei
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

6.  Study on Status and Willingness towards Hepatitis B Vaccination among Migrant Workers in Chongqing, China: A Cross-Sectional Study.

Authors:  Hui Xiang; Xiaojun Tang; Meng Xiao; Lin Gan; Kun Chu; Shan Li; Yu Tian; Xun Lei
Journal:  Int J Environ Res Public Health       Date:  2019-10-22       Impact factor: 3.390

7.  Assessing Hepatitis B Knowledge Among Native Hawaiians and Pacific Islanders in San Diego.

Authors:  Siotame Lasitani; Christopher Hattori; Teini Elisara; Maria Rosario Araneta
Journal:  J Immigr Minor Health       Date:  2021-07-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.